CAS: 112-92-5; 1-Hydroxyoctadecane

上下游产品

CAS号57-11-4 硬脂酸 | CAS号143-28-2 油醇 | CAS号112-61-8 硬脂酸甲酯 | CAS号112-80-1 油酸 | CAS号65598-00-7 tert-butyl-dime... | CAS号89538-90-9 2-°Ctadecoxypro... | CAS号3886-90-6 N,N-二甲基硬脂酰胺 | CAS号66938-10-1 2-°Ctadecoxyoxane | CAS号638-66-4 十八醛 | CAS号111-61-5 硬脂酸乙酯 | CAS号10578-34-4 硬脂醇苯甲酸酯 | CAS号638-66-4 十八醛 | CAS号1119-75-1 十八烷酸-2-氯乙酯 | CAS号105644-68-6 1-(methoxymetho... | CAS号5337-41-7 三硬脂酰硼酸酯 | CAS号1929-89-1 N-苯基-2-呋喃羧酰胺 | CAS号492-94-4 糠偶酰 | CAS号82701-01-7 °Ctadecyl furan... | CAS号34184-41-3 4-氯苯磺酸十八烷基酯 | CAS号51637-93-5 氯甲酸十八烷基酯

Stearyl Trityl Ether置于lithium Chloride体系中,用 甲醇 用作溶剂,化学反应 12.0H,以88%的收率获得硬脂醇
参考文献:Licl介导的,简便且低成本的方法,从受保护的醇和二醇中去除三苯甲基
标题:Licl介导的,简便且低成本的方法,从受保护的醇和二醇中去除三苯甲基
摘要:伯,仲,苯基,烯丙基和苄基三苯甲基醚与氯化锂在甲醇中在回流下的反应导致三苯甲基的脱保护,从而在温和的反应条件下以非常好或优异的收率获得相应的醇.
Doi:10.1016/j.Tetlet.2016.06.110

专利信息

专利号:US-10730904-B2
优先权日:2012-11-14
标 题:Method for liquid-phase synthesis of nucleic acid
发明人：NONOGAWA MITSURU; NAGATA TOSHIAKI; SAITO HIDEKI; YASUMA TSUNEO
权利人:TAKEDA PHARMACEUTICALS CO
摘要:In this method, an oligonucleotide represented by formula (II) [wherein Y 1 , Q, Base, r and r′ are each as defined in claim 1 ] is prepared by using, as a synthesis unit, a novel nucleoside monomer compound represented by formula (I) [wherein X, R 1 , Y, Base, Z, Ar, R 2 , R 3 and n are each as defined in claim 1 ]. The novel nucleoside monomer compound is a nucleoside, the base moiety of which is substituted with an aromatic-hydrocarbon-ring-carbonyl or -thiocarbonyl group having at least one hydrophobic group. The method can dispense with column-chromatographic purification in every reaction, and enables base elongation not only in the 3′-direction but also in the 5′-direction, thus attaining efficient liquid-phase mass synthesis of an oligonucleotide.

专利号:US-9597327-B2
优先权日:2005-05-25
标 题:Synthesis of (R)-N-methylnaltrexone
发明人：DOSHAN HAROLD D; PEREZ JULIO
权利人:PROGENICS PHARM INC
摘要:This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.

专利号:US-9757317-B2
优先权日:2014-09-12
标题 :Cosmetic compositions and methods for inhibiting melanin synthesis
发明人：LAUGHLIN II LEO TIMOTHY; HAKOZAKI TOMOHIRO; GUPTA SHIKHAR
权利人:PROCTER & GAMBLE
摘要:A cosmetic composition suitable for topical application, for example, is provided. In some examples, the cosmetic composition may include bisabolol, undecylenoyl phenylalanine and/or hexyldecanol, and a material selected from the group consisting of ethyl palmitate, stearyl alcohol, bis (2-ethylhexyl) adipate, bis (2-ethylhexyl) maleate, 5-pentadecanol, 1-stearoyl-rac-glycerol, bis (2-ethylhexyl) sebacate, and mixtures thereof. A method of reducing the synthesis of melanin by using the cosmetic compositions is also disclosed herein.

专利号:US-2006052577-A1
优先权日:2001-02-06
标题:Methods of synthesis of polymers and copolymers from natural products
发明人：SWIFT GRAHAM; WESTMORELAND DAVID G; HUGHES KATHLEEN
权利人:SWIFT GRAHAM; WESTMORELAND DAVID G; HUGHES KATHLEEN
摘要:Described are polymers and copolymers containing sorbitol, citric acid, starch, aspartic acid, succinic anhydride, adipic acid mixtures thereof, methods of their synthesis and their uses.

专利号:WO-2022227554-A1
优先权日:2021-04-30
标题 :Larotaxel-fatty alcohol small molecule prodrug and construction of self-assembling nanoparticle thereof
发明人：LUO CONG; WANG YONGJUN; YANG JINCHENG; MA HONGDA; SUN JIN; HE ZHONGGUI; FENG YAO; MA ZHINING
权利人:SUZHOU YUTAI PHARMACEUTICAL TECH CO LTD
摘要:The synthesis of a larotaxel-fatty alcohol small molecule prodrug with a tumor reduction response characteristic and the construction of a self-assembling nanoparticle, and the use thereof in the preparation of a drug delivery system. Provided is a larotaxel-stearyl alcohol small molecule prodrug, which is prepared into a larotaxel-fatty alcohol prodrug nanoparticle. The larotaxel-fatty alcohol prodrug nanoparticle can be a non-PEGylated larotaxel-fatty alcohol prodrug nanoparticle, a PEG-modified larotaxel-fatty alcohol prodrug nanoparticle, a drug-loaded larotaxel-fatty alcohol prodrug nanoparticle, and an active targeting larotaxel-fatty alcohol prodrug nanoparticle. The larotaxel-fatty alcohol prodrug has few synthetic steps, a simple process, reduced synthesis costs, a high yield and easy purification, and the nanoparticle formed by the self-assembly of the larotaxel-fatty alcohol small molecule prodrug has an ultra-small particle size, which reduces the toxicity and side effects while improving the curative effect of larotaxel.

专利号:EP-1779900-B1
优先权日:2005-10-29
标 题 :Cosmetic or dermatological composition for prevention of light-induced aging
发明人：NEUFANG HARTMUT; TILL MARTINA
权利人:APOTHEKER WALTER BOUHON GMBH
摘要:Use of a composition (I) comprising vitamin A (0.02-0.09 wt.%), phytosterol (0.1-3 wt.%), vitamin E (0.5-3 wt.%) and their biochemical precursors or derivatives, for the production of cosmetic or dermatological preparation for the inhibition of a light-induced gene expression of the synthesis of a collagenase in the skin. An independent claim is included for the cosmetic or dermatological preparation comprising (I), urea (1-4 wt.%), caprylic/capric acid triglyceride (caprylic/capric triglyceride according to INCI standard), lipids, consistency agents, emulsifying agents, polymers, perfumes, preservatives and water. ACTIVITY : Dermatological. MECHANISM OF ACTION : Gene expression of synthesis of collagenase Inhibitor.